No hallucinations and full disclosure of scientific records. Scrutinise is the AI for those who can't afford to miss when the evidence on their asset changes.
The Retriever runs a structured query cascade in sequence. A paper must be resolved to a real DOI in the corpus to be cited. Free-text generation of references is architecturally impossible.
The Moderator assigns one of five verdicts based on the weight and quality of the retrieved evidence. Tier boundaries are fixed, consistent across all claims and indications, and calibrated against Cochrane systematic reviews using the GRADE certainty framework.
Scrutinise monitors your pipeline on three overlapping schedules — one that builds the foundation, one that maintains the weekly rhythm, and one that acts as a real-time tripwire for high-priority publications that materially move the underlying evidence.
Each scoring run produces a complete audit record. Nothing in the output is unverifiable.
General-purpose LLMs like OpenAI or Claude are built to provide fluent, engaging answers, not to scrutinise the scientific evidence for those who need to know.
Discovery is full-text. Synthesis is abstract-only.
Through Scrutinise's partnership with Consensus, the first tier of our retrieval cascade has full-text licensed access to papers from Elsevier, Springer Nature, Wiley, and other major publishers. This lets us identify the papers that genuinely engage a claim, including cases where the relevant evidence sits in the methods or results section rather than the abstract.
The evidence synthesis itself is drawn only from the open abstract and structured metadata of each retrieved paper. Every citation, every anchoring quote, and every passage that informs a verdict comes from material that is openly published. Scrutinise does not reproduce or surface full-text content at any stage.
DOI links in the output point to the publisher's site, so users access papers through their own institutional subscriptions. The architecture lets us search deeper than any abstract-only system while remaining fully compliant with scientific publishing licences.